LISA HOEHN: Open Payments
NPI 1124015847 · FLOMATON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 20 payments from 11 companies in 2025. Trend: 2023 $199 · 2024 $380 · 2025 $494
Food & beverage: $475Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $136 |
| Travere Therapeutics, Inc. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Vifor Pharma, Inc. | 1 | $24 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
Products named: KRYSTEXXA, Kerendia, JARDIANCE, Fabhalta, Veltassa, RAYALDEE, FARXIGA, VOYXACT.
Industry payments across AL — which companies pay providers there.
